openPR Logo
Press release

Nanosonics announces first authorised European distributors

12-01-2008 12:42 PM CET | Health & Medicine

Press release from: Nanosonics Europe GmbH

/ PR Agency: pluspool GmbH
Nanosonics announces first authorised European distributors

Hamburg, Germany, November 17: Nanosonics (ASX:NAN; FSE:OQS) has formally appointed its first exclusive distributors in Europe located in Germany, Austria, Switzerland, Italy, France and Scandinavia.

According to Nanosonics’ Director and CEO David Radford, this represents the achievement of another key milestone in the commercialisation of the company’s launch product, the Trophon EPR, scheduled for March 2009.

The Trophon EPR is an environmentally friendly device specifically designed to disinfect intracavity and surface ultrasound transducers. The product represents Nanosonics’ first commercial application of one of its core technologies, the NanoNebulant™ technology.
Compared to existing disinfection solutions, the Trophon EPR marks the beginning of a new level of disinfection: High Level Disinfection+, including sporicidal efficacy.

“We feel that there is strong demand for this unique product in ultrasound and infection control markets worldwide. The critical success factor will be the adoption of quality standards that provide for high level disinfection of ultrasound transducers. We are planning to overcome these challenges through beneficial cooperations with outstanding distribution partners in each country“, David Radford said.

Nanosonics is proceeding to establish a distribution infrastructure which will provide a sustainable competitive advantage for future growth. “The dealer contracts signed in Europe already commit a considerable increase well above our internal sales projections and consumables from these device sales will provide a secondary ongoing revenue stream”, David continued.

Further negotiations with well respected dealers located in other European, Asian and African countries are in progress and supposed to be successfully completed soon.

For more information about Nanosonics, the Trophon EPR and the NanoNebulant™ technology please visit the website http://www.nanosonics.eu/.

World Headquarters:

Nanosonics Ltd.
Unit 24, 566 Gardeners Road
Alexandria NSW 2015
Australia

www.nanosonics.com.au

European Headquarters:

Nanosonics Europe GmbH
Falkenried 88, House E
20251 Hamburg
Germany

www.nanosonics.eu

Media Contact Europe:

pluspool GmbH
Ballindamm 26
20095 Hamburg
Germany

nikola.heimann@plus-pool.de

About Nanosonics

The company is of Australian origin, located in Alexandria, Sydney, with European headquarters in Hamburg, Germany. Nanosonics is listed on the Australian Securities Exchange (NAN) and Frankfurt Stock Exchange (OQM) since 2007.

The company owns intellectual property relating to unique disinfection and sterilisation technologies which can be suited to a variety of markets including the healthcare industry, food processing, room and space decontamination and manufacturing.

Nanosonics is currently focused on developing infection control solutions for the global healthcare market. Initial applications are designed for the reprocessing of reusable medical instruments. The Trophon EPR is specifically designed to disinfect intracavity and surface ultrasound probes. Based on the NanoNebulant™ technology it surpasses the limitations of current methods by killing the most resilient micro-organisms, in a fast, safe and convenient way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nanosonics announces first authorised European distributors here

News-ID: 61185 • Views:

More Releases from Nanosonics Europe GmbH

Ultrasound Transducer Disinfection in many Cases insufficient - New ‘Trophon EPR’ Device offers unique Solution
Ultrasound Transducer Disinfection in many Cases insufficient - New ‘Trophon E …
Hamburg, December 5, 2008: Current methods of ultrasound transducer disinfection are in many cases not sufficient for clinical practice. This is the latest alarming result issued by the Center for Disease Control and Prevention (CDC), the leading US public health agency, in its recently published Guideline for Disinfection and Sterilization in Healthcare Facilities (1). The guideline is the CDC’s response to the rapidly evolving epidemiology of hospital-acquired infections such

More Releases for European

European Gastroenterology Congress
Peers Alley Media Conferences would like to invite all the outstanding gastroenterologists, gastroenterology surgeons, scientists, academicians, young researchers, business delegates and students from all around the world to attend European Gastroenterology Congress from March 23-24, 2020 in Paris, France. This conference gives an unparalleled opportunity to network with colleagues and learn from the different leaders in gastroenterology research. This conference makes a perfect platform for global networking as it brings together the
23rd European Nephrology Conference
23rd European Nephrology Conference is the world’s leading conference for Nephrology professionals to gather and contribute their research for developing the new techniques in the field of Nephrology. Nephrology Conferences offers over 30 sessions from different areas in the field of Nephrology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations. Nephrology Conferences which is going to be held in global & ancient city Rome, Italy
27th European Diabetes Congress
Rising awareness, new technologies and practical approaches within the field of diabetes and endocrine disorders in world’s leading diabetes Conferences One in eight ladies can develop a diabetes disorder throughout her lifespan. And, the amount of individuals affected by diabetes disorders continues to rise every year. However the larger drawback is that almost 60 minutes of those individuals are fully unaware of their condition as well as a way to heal
4th European Biopharma Congress
Biopharmaceuticals Conference Series Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria. The opportunity in biopharmaceuticals is big and growing too
18th European Diabetes Congress
It takes us immense pleasure to announce the conference that 18th European Diabetes Congress which is going to be held during July 17-18, 2017 at Lisbon, Portugal. Euro Diabetes 2017 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Diabetes
PRISMA European Capacity Platform named Project of the Year at European Gas Conf …
The brand new PRISMA European Capacity Platform, BP’s Vice President for Shah Deniz, Al Cook, and Dr Jonathan Stern of the Oxford Institute for Energy Studies, were honoured at the annual European Gas Conference Awards at the Palais Coburg in Vienna on Wednesday evening. During the awards ceremony, which was attended by leading experts from the European gas industry, PRISMA was named Project of the Year; Al Cook was